Skip to main content

Together we are beating cancer

Donate now

Immune system

Showing 12 out of 113 results
A medical professional drawing a dose of a vaccine from a vial with a syringe

Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service Thousands of cancer patients in England are set to gain fast-tracked access to trials of personalised cancer vaccines following the launch of a world-leading NHS trial ‘matchmaking' service

by Jacob Smith | News | 31 May 2024

31 May 2024

Cells with nuclei in blue and mitochondria (energy factories) in green.

Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people. Our researchers have found mutations that make cancers much more likely to respond to immunotherapy. It's a chance to make breakthrough treatments work for many more people.

by Tim Gunn | Analysis | 31 January 2024

31 January 2024

Antibody

Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug... Follow Sophia Karagiannis and James Spicer on an immunological adventure as they develop a ground-breaking new class of drug...

by Cancer Research UK | In depth | 12 December 2023

12 December 2023

A mouse-eared bat flying out of a cave

Bats rarely get cancer. They also resist viruses that kill humans, and some don't even seem to age. Scientists think that it might have something to do with their ability to fly – and that we can copy some of their tricks. Bats rarely get cancer. They also resist viruses that kill humans, and some don't even seem to age. Scientists think that it might have something to do with their ability to fly – and that we can copy some of their tricks.

by Tim Gunn | Analysis | 31 October 2023

31 October 2023

Vaccine vial and needle
  • Science & Technology
  • Health & Medicine

Cancer vaccines – where are we?

Cancer vaccine development has had many challenges. But with recent breakthroughs and new partnerships, could we be closer than ever? Cancer vaccine development has had many challenges. But with recent breakthroughs and new partnerships, could we be closer than ever?

by Sophie Wedekind | In depth | 24 February 2023

24 February 2023

The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects... The Antibody Alliance Laboratory – a collaboration between Cancer Research UK and AstraZeneca – combines academic rigour with agile bioengineering to push forward antibody discovery projects...

by Cancer Research UK | In depth | 15 December 2022

15 December 2022

T cell

Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs Researchers in Southampton have found a way to improve the effectiveness of immunotherapy in cancers that are resistant by repurposing existing drugs

by Jacob Smith | Analysis | 11 November 2022

11 November 2022

A patient receiving chemotherapy

A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer. A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

by Jacob Smith | News | 2 May 2022

2 May 2022

Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials... Forty years ago, hints of a new component of the immune system caused a stir. Here, we chart the story of gamma delta T cells from discovery to clinical trials...

by Cancer Research UK | In depth | 18 March 2022

18 March 2022

A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works. A team of our scientists at University College London have developed a potential new immunotherapy drug and caused another paradigm shift in our understanding of how cancer immunotherapy works.

by Lilly Matson | Analysis | 9 November 2020

9 November 2020

Lung cancer cells

There are many unanswered questions about how and why cancer spreads around the body. But one thing we do know is that only some cancers metastasise. There are many unanswered questions about how and why cancer spreads around the body. But one thing we do know is that only some cancers metastasise.

by Kerry Noble | Analysis | 26 November 2019

26 November 2019

This entry is part 20 of 23 in the series Science Surgery